AU5971294A - Agent, intended for transdermal administration, containing 14alpha,17alpha-ethanoestra-1,3,5(10)-triene-3,17beta -diol - Google Patents

Agent, intended for transdermal administration, containing 14alpha,17alpha-ethanoestra-1,3,5(10)-triene-3,17beta -diol

Info

Publication number
AU5971294A
AU5971294A AU59712/94A AU5971294A AU5971294A AU 5971294 A AU5971294 A AU 5971294A AU 59712/94 A AU59712/94 A AU 59712/94A AU 5971294 A AU5971294 A AU 5971294A AU 5971294 A AU5971294 A AU 5971294A
Authority
AU
Australia
Prior art keywords
ethanoestra
14alpha
17alpha
17beta
triene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59712/94A
Inventor
Clemens Gunther
Ralph Lipp
Jutta Riedl
Ulrich Tauber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU5971294A publication Critical patent/AU5971294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
AU59712/94A 1994-01-27 1994-01-27 Agent, intended for transdermal administration, containing 14alpha,17alpha-ethanoestra-1,3,5(10)-triene-3,17beta -diol Abandoned AU5971294A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1994/000213 WO1995020392A1 (en) 1994-01-27 1994-01-27 AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14α,17α-ETHANOESTRA-1,3,5(10)-TRIENE-3,17β-DIOL

Publications (1)

Publication Number Publication Date
AU5971294A true AU5971294A (en) 1995-08-15

Family

ID=8165820

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59712/94A Abandoned AU5971294A (en) 1994-01-27 1994-01-27 Agent, intended for transdermal administration, containing 14alpha,17alpha-ethanoestra-1,3,5(10)-triene-3,17beta -diol

Country Status (6)

Country Link
EP (1) EP0741572A1 (en)
JP (1) JPH09510697A (en)
AU (1) AU5971294A (en)
FI (1) FI962993A (en)
NO (1) NO963128L (en)
WO (1) WO1995020392A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19526864A1 (en) * 1995-07-22 1997-01-23 Labtec Gmbh Hormone patches
EP1443964B1 (en) * 2001-11-09 2008-02-20 QLT Inc. Photodynamic therapy for the treatment of hair loss

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
CH674618A5 (en) * 1987-04-02 1990-06-29 Ciba Geigy Ag
ES2081823T3 (en) * 1988-10-27 1996-03-16 Schering Ag AGENT FOR TRANSDERMIC APPLICATION, CONTAINING GESTODEN.
DE3838779A1 (en) * 1988-11-11 1990-05-17 Schering Ag 14 (ALPHA), 17 (ALPHA) ETHANO ESTRATRIENE
DE4227989A1 (en) * 1992-08-21 1994-06-09 Schering Ag Agent for transdermal application containing 3-keto-desogestrel

Also Published As

Publication number Publication date
NO963128D0 (en) 1996-07-26
NO963128L (en) 1996-07-26
WO1995020392A1 (en) 1995-08-03
FI962993A0 (en) 1996-07-26
FI962993A (en) 1996-07-26
EP0741572A1 (en) 1996-11-13
JPH09510697A (en) 1997-10-28

Similar Documents

Publication Publication Date Title
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
AU9028498A (en) System, method and cassette for mixing and delivering intravenous drugs
ZA962536B (en) Pharmaceutical composition for transdermal administration.
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
EP0811595A4 (en) Hydrochalcone derivatives, comestic compositions containing the same, and processes for the preparation of both
AU2387997A (en) Stabilized medicaments containing cysteinyl derivatives
AUPN411195A0 (en) Medicinal composition
IL111533A0 (en) Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
AU2094397A (en) New arylglycinamide derivatives, processes for preparing them and pharmaceutical compositions containing these compounds
AU5108196A (en) Imidazoquinazolines, drugs containing these compounds, their use and process for their preparation
IL113103A0 (en) Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU1689999A (en) Medicinal composition for percutaneous administration
AU1673297A (en) Therapeutic agent for diabetes
AU6998196A (en) Medicinal composition for diabetes
AU2531295A (en) Pharmaceutical composition
AU3011095A (en) 2,3-bridged 1,4-dihydropyridines, processes for their preparation and their use as medicaments
GB9310075D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
AU4636396A (en) Antiglucocorticoid medicament
AU3519495A (en) Novel drugs containing chelate-forming agents
AU5971294A (en) Agent, intended for transdermal administration, containing 14alpha,17alpha-ethanoestra-1,3,5(10)-triene-3,17beta -diol
IL128238A0 (en) 11-Acetyl-12, 13-dioxabicyclo [8.2.1]-tridecenone derivatives processes for the preparation thereof and medicaments containing these compounds
AU1110699A (en) Estra-1,3,5(10)-triene-7alpha-thioethers
AU685006B2 (en) Metallocenic diarylethylene derivatives, methods for their preparation and pharmaceutical compositions containing same
HU9602061D0 (en) Agent, intended for transdermal administration, containing 14alfa, 17alfa-ethanoestra-1,3,5(10)-triene-3,17beta-diol
AU8562998A (en) Idebenone-containing preparation for percutaneous administration